General Information of This Antibody
Antibody ID
ANI0GDTIL
Antibody Name
Anti-PSMA mAb hD7-1
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG
Antigen Name
Glutamate carboxypeptidase 2 (FOLH1)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
hD7-1 (VL-VH)-PE40 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
37.00 pM
Positive PSMA expression (PSMA+++/++)
Method Description
The immunotoxins hD7-1 (VL-VH)-PE40 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
In Vitro Model Lymph node metastasis of prostate carcinoma LNCaP C4-2 cells CVCL_4782
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
55.00 pM
Positive PSMA expression (PSMA+++/++)
Method Description
The immunotoxins hD7-1 (VL-VH)-PE40 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
In Vitro Model Prostate carcinoma LNCaP cells CVCL_0395
hD7-1 (VL-VH)-PE24mut [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
39.00 pM
Positive PSMA expression (PSMA+++/++)
Method Description
The immunotoxins hD7-1 (VL-VH)-PE24mut was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
In Vitro Model Lymph node metastasis of prostate carcinoma LNCaP C4-2 cells CVCL_4782
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
0.18 nM
Positive PSMA expression (PSMA+++/++)
Method Description
The immunotoxins hD7-1 (VL-VH)-PE24mut was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
In Vitro Model Prostate carcinoma LNCaP cells CVCL_0395
hD7-1 (VL-VH)-PE24 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
0.12 nM
Positive PSMA expression (PSMA+++/++)
Method Description
The immunotoxins hD7-1 (VL-VH)-PE24 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
In Vitro Model Prostate carcinoma LNCaP cells CVCL_0395
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
0.13 nM
Positive PSMA expression (PSMA+++/++)
Method Description
The immunotoxins hD7-1 (VL-VH)-PE24 was tested for specific cytotoxic activity against PSMA-positive LNCaP and C4-2 cells.
In Vitro Model Lymph node metastasis of prostate carcinoma LNCaP C4-2 cells CVCL_4782
References
Ref 1 In Vitro Evaluation of Humanized/De-immunized Anti-PSMA Immunotoxins for the Treatment of Prostate Cancer. Anticancer Res. 2018 Jan;38(1):61-69. doi: 10.21873/anticanres.12192.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.